This doctor wants the new HIV drug to be available to every South African

In Episode 15 of The Odds in Our Favour, Saskia Falken chats to Dr Tom Ellman of Doctors Without Borders about the new HIV prevention breakthrough, Lenacapavir, and asks: “Who will actually get it?” While science moves forward, access remains shaped by patents, pricing and power. Médecins Sans Frontières (MSF) – also known as Doctors Without Borders – is an organisation known for delivering frontline medical care in some of the world’s most underserved and crisis-affected regions. Ellman shares what this drug means, how it works, and why MSF is engaging pharmaceutical company Gilead Sciences in the fight for equitable access. At its heart, this is a conversation about whether progress is real if it isn’t shared. This episode was proudly brought to you by Old Mutual Wealth – helping clients grow, protect, and preserve what matters most with investment strategies designed to support your legacy. Comment below. The full edition drops every Friday at 07:00 on Spotify, Apple Music, and YouTube. The show is produced by An Wentzel and quality-checked by News24's editors.